532 related articles for article (PubMed ID: 9527715)
1. [Tacrine].
Dávila C; Viteri C; de Castro P
Rev Med Univ Navarra; 1997; 41(1):58-64. PubMed ID: 9527715
[TBL] [Abstract][Full Text] [Related]
2. [Tacrine against Alzheimer disease? Still uncertain for which patients may the treatment be beneficial].
Wallin A
Lakartidningen; 1996 Jan; 93(1-2):22-4. PubMed ID: 8544526
[No Abstract] [Full Text] [Related]
3. Pharmacologic approaches to cognitive deficits in Alzheimer's disease.
Peskind ER
J Clin Psychiatry; 1998; 59 Suppl 9():22-7. PubMed ID: 9720483
[TBL] [Abstract][Full Text] [Related]
4. [Therapeutic results: tacrine].
Ventura M; Sternon J
Rev Med Brux; 1997 Dec; 18(6):394-7. PubMed ID: 9481161
[TBL] [Abstract][Full Text] [Related]
5. Treatment of Alzheimer's disease: an evaluation of the cholinergic approach.
Lemière J; Van Gool D; Dom R
Acta Neurol Belg; 1999 Jun; 99(2):96-106. PubMed ID: 10427352
[TBL] [Abstract][Full Text] [Related]
6. Maximizing function in Alzheimer's disease: what role for tacrine?
Smucker WD
Am Fam Physician; 1996 Aug; 54(2):645-52. PubMed ID: 8701842
[TBL] [Abstract][Full Text] [Related]
7. Effect of cholinesterase inhibitors on attention.
Pepeu G; Giovannini MG; Bracco L
Chem Biol Interact; 2013 Mar; 203(1):361-4. PubMed ID: 23047023
[TBL] [Abstract][Full Text] [Related]
8. Alternatives in the treatment of memory loss in patients with Alzheimer's disease.
Volger BW
Clin Pharm; 1991 Jun; 10(6):447-56. PubMed ID: 2065522
[TBL] [Abstract][Full Text] [Related]
9. Cognition-enhancing drugs in dementia: a guide to the near future.
van Reekum R; Black SE; Conn D; Clarke D
Can J Psychiatry; 1997 Jun; 42 Suppl 1():35S-50S. PubMed ID: 9220128
[TBL] [Abstract][Full Text] [Related]
10. Have cholinergic therapies reached their clinical boundary in Alzheimer's disease?
Jones RW
Int J Geriatr Psychiatry; 2003 Sep; 18(Suppl 1):S7-S13. PubMed ID: 12973745
[TBL] [Abstract][Full Text] [Related]
11. Donepezil: new preparation. Moderate efficacy in Alzheimer's disease.
Prescrire Int; 1998 Oct; 7(37):146-7. PubMed ID: 10915420
[TBL] [Abstract][Full Text] [Related]
12. Rationale for combination therapy with galantamine and memantine in Alzheimer's disease.
Grossberg GT; Edwards KR; Zhao Q
J Clin Pharmacol; 2006 Jul; 46(7 Suppl 1):17S-26S. PubMed ID: 16809811
[TBL] [Abstract][Full Text] [Related]
13. Tacrine for Alzheimer's disease.
Med Lett Drugs Ther; 1993 Sep; 35(905):87-8. PubMed ID: 8361451
[No Abstract] [Full Text] [Related]
14. Practice guidelines for the diagnosis and treatment of Alzheimer's disease in a managed care setting: Part II--Pharmacologic therapy. Alzheimer's Disease (AD) Managed Care Advisory Council.
Fillit H; Cummings J
Manag Care Interface; 2000 Jan; 13(1):51-6. PubMed ID: 10747691
[TBL] [Abstract][Full Text] [Related]
15. [Convulsive crisis as a possible adverse reaction to the treatment with tacrine in Alzheimer's disease].
García-Díaz JD; Fraguas C; Garcimartín C
Med Clin (Barc); 1998 Sep; 111(7):279. PubMed ID: 9789247
[No Abstract] [Full Text] [Related]
16. Donepezil for Alzheimer's disease.
Benjamin B; Burns A
Expert Rev Neurother; 2007 Oct; 7(10):1243-9. PubMed ID: 17939763
[TBL] [Abstract][Full Text] [Related]
17. Cholinesterase inhibitors. Comparing the options for mild-to-moderate dementia.
Conn DK;
Geriatrics; 2001 Sep; 56(9):56-7. PubMed ID: 11582975
[TBL] [Abstract][Full Text] [Related]
18. Alzheimer's disease: the role of tacrine therapy.
Jogerst G
Iowa Med; 1995 Oct; 85(10):409-11. PubMed ID: 7591656
[No Abstract] [Full Text] [Related]
19. Advances in the treatment of Alzheimer's disease.
Schneider LS
Aging (Milano); 1998 Apr; 10(2):156-7. PubMed ID: 9666210
[No Abstract] [Full Text] [Related]
20. Effect of donepezil and tacrine on oxidative stress in intracerebral streptozotocin-induced model of dementia in mice.
Saxena G; Singh SP; Agrawal R; Nath C
Eur J Pharmacol; 2008 Mar; 581(3):283-9. PubMed ID: 18234183
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
